SCHEMBL30920404

SCHEMBL30920404

COc1cc2[nH]c(CNC(=O)C3(C)CC3)cc2cc1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 5/20 0.40
▸ MTNR1B P49286 5/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ TAOK1 Q7L7X3 1/20 0.37
▸ TAOK3 Q9H2K8 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.34
▸ ADAM17 P78536 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27247690 1.00 MTNR1A (0.40) MTNR1AMTNR1BSMN1; SMN2RAB9ATAOK1
SCHEMBL27248077 0.86 RAB9A (0.39) MTNR1AMTNR1BSMN1; SMN2RAB9AHPGD
SCHEMBL30920659 0.86 RAB9A (0.39) MTNR1AMTNR1BSMN1; SMN2RAB9AHPGD
SCHEMBL27247882 0.84 SMN1; SMN2 (0.46) MTNR1AMTNR1BSMN1; SMN2RAB9AGAA
SCHEMBL27246962 0.84 RAB9A (0.41) MTNR1AMTNR1BSMN1; SMN2RAB9ANPC1
SCHEMBL30920655 0.84 MTNR1A (0.41) MTNR1AMTNR1BSMN1; SMN2RAB9AALDH1A1
SCHEMBL30920360 0.84 SMN1; SMN2 (0.46) MTNR1AMTNR1BSMN1; SMN2RAB9AGAA
SCHEMBL30920207 0.84 RAB9A (0.41) MTNR1AMTNR1BSMN1; SMN2RAB9ANPC1
SCHEMBL30920782 0.84 SMN1; SMN2 (0.40) MTNR1AMTNR1BSMN1; SMN2RAB9AALDH1A1
SCHEMBL27247432 0.84 MTNR1A (0.41) MTNR1AMTNR1BSMN1; SMN2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4601635-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
Send feedback